Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm Chen-Chung LiuHiroyoshi Takeuchi Current Opinion 18 November 2019 Pages: 117 - 126
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy Ryan D. SalinasJoseph S. DurginDonald M. O’Rourke Leading Article 08 January 2020 Pages: 127 - 145
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults Linda J. StephenMartin J. Brodie Review Article 25 January 2020 Pages: 147 - 161
Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? David S. BaldwinHugo J. F. Amaro Review Article 16 December 2019 Pages: 163 - 169
Pharmacotherapy for Cluster Headache Roemer B. BrandtPatty G. G. DoesborgRolf Fronczek Review Article Open access 29 January 2020 Pages: 171 - 184
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study Robert T. NaismithAnnette WundesThe EVOLVE-MS-2 Study Group Original Research Article Open access 17 January 2020 Pages: 185 - 196
Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study Kim S. J. LaoAngel Y. S. WongEsther W. Chan Original Research Article 08 January 2020 Pages: 197 - 206
Pitolisant: A Review in Narcolepsy with or without Cataplexy Yvette N. Lamb Adis Drug Evaluation 29 January 2020 Pages: 207 - 218